ArticleCancer letters2017
Current status of biomarker and targeted nanoparticle development: The precision oncology approach for pancreatic cancer therapy.
Lei Zhu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
34 papers cite it
this papercites it